| Sep 19 |
Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
|
| Sep 4 |
Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 15 |
Adial Pharmaceuticals reports Q2 results
|
| Aug 14 |
Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
|
| Aug 13 |
Adial Pharmaceuticals Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04
|
| Aug 13 |
EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder
|
| Aug 7 |
Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
|
| Aug 7 |
EXCLUSIVE: Adial Pharmaceuticals' Last Patient Dosed in Pharmacokinetics Study of AD04 For Alcohol Use Disorder, Data Expected In Q4
|
| Jul 31 |
Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044
|
| Jul 23 |
Crude Oil Down 2%; GE Aerospace Earnings Top Views
|
